These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2612731)
1. Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Zhou F; Bouillard B; Pharaboz-Joly MO; André J Mol Cell Endocrinol; 1989 Oct; 66(2):189-97. PubMed ID: 2612731 [TBL] [Abstract][Full Text] [Related]
2. Multihormonal control of cell proliferation: opposite effects of two stimulators (17 beta-estradiol and L-triiodothyronine) and one inhibitor (dexamethasone) on F4Z2 pituitary tumor cells. Zhou-Li F; Joly-Pharaboz MO; Bouillard B; Albaladejo V; Nicolas B; Andre J Endocrinology; 1991 Jun; 128(6):2761-8. PubMed ID: 2036960 [TBL] [Abstract][Full Text] [Related]
3. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822 [TBL] [Abstract][Full Text] [Related]
4. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281 [TBL] [Abstract][Full Text] [Related]
5. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. Vignon F; Bardon S; Chalbos D; Rochefort H J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424 [TBL] [Abstract][Full Text] [Related]
6. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. van den Berg HW; Martin J; Lynch M Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Uht RM; Anderson CM; Webb P; Kushner PJ Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. Horwitz KB; Freidenberg GR Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533 [TBL] [Abstract][Full Text] [Related]
10. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Simard J; de Launoit Y; Haagensen DE; Labrie F Endocrinology; 1992 Mar; 130(3):1115-21. PubMed ID: 1537279 [TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
12. Progesterone and dexamethasone inhibition of estrogen-induced synthesis of DNA and complement in rat uterine epithelium: effects of antiprogesterone compounds. Bigsby RM J Steroid Biochem Mol Biol; 1993 Apr; 45(4):295-301. PubMed ID: 8499337 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
14. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871 [TBL] [Abstract][Full Text] [Related]
15. Effects of steroid hormones and antihormones in cultured cells. Jung-Testas I; Baulieu EE Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615 [TBL] [Abstract][Full Text] [Related]
16. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. Chen FP; Chien MH; Chen HY; Huang TS; Ng YT Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen attenuates glucocorticoid actions on bone formation in vitro. Sukhu B; Rotenberg B; Binkert C; Kohno H; Zohar R; McCulloch CA; Tenenbaum HC Endocrinology; 1997 Aug; 138(8):3269-75. PubMed ID: 9231777 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803 [TBL] [Abstract][Full Text] [Related]
19. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Poulin R; Baker D; Poirier D; Labrie F Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057 [TBL] [Abstract][Full Text] [Related]